What is Iovance Biotherapeutics, Inc.'s deferred taxes?

Iovance Biotherapeutics, Inc. (IOVA) reported deferred taxes of -$665K in Q1 2026.

How has Iovance Biotherapeutics, Inc.'s deferred taxes changed year-over-year?

Iovance Biotherapeutics, Inc.'s deferred taxes increased by 63.8% year-over-year, from -$1.84M to -$665K.

What does deferred taxes mean?

Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.

Iovance Biotherapeutics, Inc. IOVA Deferred Taxes

Deferred Taxes at other companies

Bristol-Myers SquibbBMY

$161M-27.8%

Gilead SciencesGILD

$179M+190%

IncyteINCY

$63.42M+1,046%

BiogenBIIB

$23.6M+185%

DanaherDHR

$110M-8.9%

TG TherapeuticsTGTX

$3.86M—

Other financials

Income statement

See full

Revenue$71.4M+44.8%

Gross profit$28.9M+338%

Operating income-$81.0M+33.1%

Net income-$79.0M+32.0%

EPS (diluted)-$0.19+47.2%

Balance sheet

See full

Cash & equivalents$196.5M+14.5%

Total debt$46.8M-11.3%

Total equity$721.8M-6.0%

Total assets$925.7M-4.2%

Cash flow

See full

Operating cash flow-$72.1M+30.5%

CapEx$6.6M+6.4%

Free cash flow-$78.7M+28.4%

Valuation

See full

Market cap$1.9B+32.4%

Profitability

See full

Gross margin36.7%+4.1pp

Operating margin-127.2%-31.0pp

Net margin-123.9%-28.4pp

FCF margin-106.8%-27.5pp

Returns & leverage

See full

Return on equity-47.5%-3.7pp

Debt / equity0.1×0.0×

Current ratio3.6×-0.6×

Where this comes from

Reported directly by Iovance Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.

The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Iovance Biotherapeutics, Inc.'s deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Iovance Biotherapeutics, Inc.'s deferred taxes?: Iovance Biotherapeutics, Inc. (IOVA) reported deferred taxes of -$665K in Q1 2026.
How has Iovance Biotherapeutics, Inc.'s deferred taxes changed year-over-year?: Iovance Biotherapeutics, Inc.'s deferred taxes increased by 63.8% year-over-year, from -$1.84M to -$665K.
What does deferred taxes mean?: Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.